For decades, the hardwood forests of northern Pennsylvania have been subjected to chronic atmospheric loading of acidifying agents. On marginal, high-elevation, unglaciated sites, sugar maples (Acer saccharum Marsh.) have experienced severe decline symptoms and mortality. Accelerated soil acidification, base cation leaching, and increased availability of toxic metals have been suggested as predisposing factors contributing to this decline. Manganese, an essential micronutrient, is also a potentially phytotoxic metal that may be a factor associated with poor sugar maple health on soils vulnerable to acidification from anthropogenic sources. We measured Mn levels in four compartments of the soil-tree system (soil, foliage, xylem wood, and sap) on three sugar maple stands in northern Pennsylvania. Two stands were classified as declining and one was in good health. Negative correlations were found between soil pH and Mn levels in the soil, foliage, sap, and xylem wood. Levels of Mn in these pools were consistently higher on declining sites, which correspondingly exhibited lower levels of Ca and Mg. Species differences between red maple (Acer rubrum L.) and sugar maple at the two declining sites suggested different tolerances to excessive Mn. Molar ratios of Mg/Mn and Ca/Mn were different among sites and showed potential as indicators of soil acidification. Significant correlations among soil, sap, foliage, and xylem wood Mn were also noted. These results show clear Mn differences among sites and, when viewed with recent Mn toxicity experiments and other observational studies, suggest that excessive Mn may play a role in the observed decline and mortality of sugar maple.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2134/jeq2004.0347 | DOI Listing |
Alzheimers Res Ther
January 2025
Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University, No. 155, Sec. 2, Linong St., Beitou, Taipei, 112304, Taiwan.
Background: Effective treatment for Alzheimer's disease (AD) remains an unmet need. Thus, identifying patients with mild cognitive impairment (MCI) who are at high-risk of progressing to AD is crucial for early intervention.
Methods: Blood-based transcriptomics analyses were performed using a longitudinal study cohort to compare progressive MCI (P-MCI, n = 28), stable MCI (S-MCI, n = 39), and AD patients (n = 49).
Alzheimers Dement
December 2024
Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge, United Kingdom.
Background: Frontotemporal dementia (FTD) and Progressive Supranuclear Palsy (PSP) have distinct molecular pathologies, with Tau and TDP43 aggregation, and distinct patterns of regional brain atrophy. However, they share the synaptotoxicity of protein aggregation, and neurotransmitter loss (including GABA), which contribute to clinical and neurophysiological similarities. Defining the relationships between synaptic loss, network physiology and cognition builds bridges between preclinical and clinical studies, and facilitates early phase trials.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
School of Medicine of Ribeirão Preto, University of São Paulo, RIBEIRAO PRETO, Brazil.
Background: Families with a history of Alzheimer's Disease (AD) may have a genetic predisposition that raises the risk of developing the condition. However, not all members of these families can undergo genetic testing. Thus, this study aims to evaluate specific cognitive changes, neuropsychiatric symptoms (NPS), and personality traits that may act as early indicators of AD in family members compared to controls.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
University of Naples Federico II, Napoli, Italy.
Background: Drugs with anticholinergic properties are frequently prescribed to patients with cognitive impairment. The cholinergic system plays an important role in the learning process, memory, but also in the regulation of emotions. The aim of this research is to investigate a possible correlation between the use of anticholinergic drugs and the risk of developing more severe behavioral and psychological symptoms (BPSD).
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Universidad Autónoma de Caribe, Barranquilla, Colombia.
Background: Assessments for early-stage Alzheimer's disease (AD) aim to identify neuropsychological and functional impairments, which rarely correlate with early disease stages. We need to enhance our understanding of the cognitive aspects contributing to functional decline to improve sensitivity in functional assessment. The ability to bind information in memory declines in preclinical AD stages.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!